4//SEC Filing
Kender Richard N 4
Accession 0000950170-25-053246
CIK 0001609809other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:05 PM ET
Size
5.3 KB
Accession
0000950170-25-053246
Insider Transaction Report
Form 4
Kender Richard N
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-10+100,000→ 100,000 totalExercise: $0.58Exp: 2035-04-09→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of April 10, 2026 or the day immediately prior to the company's 2026 annual meeting of shareholders.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001381205
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:05 PM ET
- Size
- 5.3 KB